5-FdUrd-araC heterodinucleoside re-establishes sensitivity in 5-FdUrd- and AraC-resistant MCF-7 breast cancer cells overexpressing ErbB2. [electronic resource]
Producer: 20070227Description: 488-98 p. digitalISSN:- 0301-4681
- Antimetabolites, Antineoplastic -- chemistry
- Apoptosis
- Breast Neoplasms -- drug therapy
- Caspase 7 -- metabolism
- Cell Cycle -- drug effects
- Cell Proliferation -- drug effects
- Cyclin D1 -- antagonists & inhibitors
- Cytarabine -- analogs & derivatives
- Dimerization
- Drug Resistance, Neoplasm
- Female
- Floxuridine -- analogs & derivatives
- Humans
- Receptor, ErbB-2 -- metabolism
- Tumor Cells, Cultured
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.